Solara Active Pharma Sciences peers

·Pharma & HealthChart ›

Companies like Solara Active Pharma Scienceslatest year

Solara Active Pharma SciencesSOLARA · FY26 · this company
Market cap₹2,910
P/E—
Sales growth+33.1%
ROE−0.6%
Ind-Swift LaboratoriesINDSWFTLAB · FY26
Open ›
Market cap₹3,291
P/E76.56×
Sales growth+57.5%
ROE3.2%
Dishman Carbogen AmcisDCAL · FY26
Open ›
Market cap₹2,334
P/E23.93×
Sales growth−4.3%
ROE1.6%
SMS PharmaceuticalsSMSPHARMA · FY26
Open ›
Market cap₹4,453
P/E42.64×
Sales growth+5.6%
ROE14.3%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SOLARA₹653.80

Solara Active Pharma Sciences Limited

· Pharma & Health
₹ CrorePeersINDSWFTLABDCALSMSPHARMAHIKALPANACEABIOSAIPARENTINDOCOUNICHEMLABMcap ₹2,910 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SOLARA
FY26
INDSWFTLAB
FY26
DCAL
FY26
SMSPHARMA
FY26
Peer
Average
Valuation — at last close
P/E—76.56×◆ 23.93×42.64×47.71×
P/B2.32×2.38×◆ 0.35×5.67×2.80× -17%
EV/EBITDA18.87×63.57×◆ 7.25×27.86×32.89× -43%
Market Cap₹2,910 Cr₹3,291 Cr₹2,334 Cr₹4,453 Cr₹3,359 Cr -13%
Growth
Revenue CAGR 3Y-1.76%-19.01%6.71%◆ 19.32%2.34% -175%
Revenue CAGR 5Y-3.27%—8.93%◆ 9.51%9.22% -135%
Net Income CAGR 3Y—-4.53%——-4.53%
Revenue YoY (latest Q)33.11%◆ 57.53%-4.29%5.57%19.60% +69%
Net Income YoY (latest Q)◆ 381.78%328.31%-347.24%2.04%-5.63% +6881%
Profitability
EBITDA Margin13.64%7.03%19.29%◆ 19.31%15.21% -10%
Net Income Margin-0.54%6.46%3.32%◆ 11.50%7.09% -108%
Return on Common Equity-0.63%3.24%1.56%◆ 14.32%6.37% -110%
Return on Capital Employed6.39%1.10%2.57%◆ 14.30%5.99% +7%
Return on Assets-0.32%2.66%0.89%◆ 8.11%3.89% -108%
Credit & Quality
Total Debt/Equity0.53×◆ 0.01×0.42×0.46×0.30× +79%
Interest Coverage0.92×◆ 10.31×1.30×5.69×5.77× -84%
Scale — latest FY
Revenue / Total Income₹1,369 Cr₹641 Cr₹2,932 Cr₹887 Cr₹1,487 Cr -8%
Net Income−₹7.4 Cr₹41.4 Cr₹97.5 Cr₹102 Cr₹80.3 Cr -109%
Total Assets₹2,333 Cr₹1,673 Cr₹11,923 Cr₹1,362 Cr₹4,986 Cr -53%
EPS₹-1.68₹4.95₹6.22₹11.15₹7.44 -123%
Book Value per Share₹281.48₹159.38₹425.82₹83.91₹223.04 +26%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.